A117 (Zolpidem tartrate extended release 6.25 mg)

Pill imprint A117 has been identified as Zolpidem tartrate extended release 6.25 mg.

Zolpidem is used in the treatment of insomnia and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. Risk cannot be ruled out during pregnancy. Zolpidem 6.25 mg has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.

See also related documents.

Images for A117 (Zolpidem tartrate extended release 6.25 mg)

Zolpidem tartrate extended release 6.25 mg A117
Zolpidem tartrate extended release 6.25 mg A117
Zolpidem tartrate extended release
Imprint:
A117
Strength:
6.25 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Miscellaneous anxiolytics, sedatives and hypnotics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
4 - Some potential for abuse
Manufacturer:
Anchen Pharmaceuticals Inc.
National Drug Code (NDC):
10370-0117
Inactive Ingredients:
silicon dioxide
hypromelloses
magnesium stearate
polyethylene glycol
sucrose
titanium dioxide
D&C Yellow No. 10
FD&C Yellow No. 6
polyvinyl alcohol
magnesium silicate

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web3)